Literature DB >> 24303293

Analyzing disease-associated protein structures with visual analytics.

Dennis Bromley1, Valerie Daggett.   

Abstract

Protein function is related to protein structure, and understanding disease-associated structural changes is critical both to understanding protein-mediated illness and to developing clinical therapies. We have developed a visual analytics tool called ContactWalker that uses molecular dynamics simulations to investigate the structural and physical differences between wild type and disease-associated protein structures. This tool has been used successfully to characterize the effects of the disease ataxia with vitamin E deficiency (AVED). We are now beginning to investigate mutations to other disease-associated proteins including the tumor suppressor protein p53.

Entities:  

Year:  2013        PMID: 24303293      PMCID: PMC3814492     

Source DB:  PubMed          Journal:  AMIA Jt Summits Transl Sci Proc


INTRODUCTION AND BACKGROUND:

Understanding protein structure is crucial to molecular disease research; molecular dynamics (MD) simulation is an in silico technique that provides high-resolution time-series data about protein dynamic structure. Unfortunately, MD simulations produce orders of magnitude more data than X-ray crystallography or NMR; datasets of this size are, as a unit, often too large for conventional tools.

METHODS:

To address this problem, we developed an interactive-speed visual analytics tool called ContactWalker1 that uses multiple MD simulations to calculate structural and physical differences between wild type and disease-associated protein structures. ContactWalker provides interactive access to the MD data and displays differences in protein structure via graph layout and protein structure visualization.

RESULTS:

We initially used ContactWalker to investigate ataxia with vitamin E deficiency (AVED), a neurodegenerative disease caused by mutations to the α-tocopherol transfer protein1; by analyzing differences in interatomic contacts, we characterized the mutation-associated structural differences, rationalized those findings with experiment, and offered a molecular-level explanation for the effects of the disease. We have since added additional physical analyses to ContactWalker and are now be eginning to investigate other mutant protein systems, including the tumor-suppressor protein p53. Figure 1 shows ContactWalker analysis of the p53 Y220C mutant. Figure 1A shows networks of mutation-associated disrupted contacts running through the protein. The focus box highlights the most disturbed region of the protein. This region, when mapped onto the protein structure (Fig. 1B), aligns with the location of a ligand binding pocket found experimentally to stabilize and rescue the mutant protein and to restore function2.
Figure 1.

p53 residues stabilized (green) and destabilized (orange) by the Y220C mutation. (A) ContactWalker output. (B) Protein structure.

DISCUSSION:

The figure above represents a differential summary of tens of gigabytes and hundreds of nanoseconds of MD data. Through simple and powerful interaction techniques, ContactWalker is able to pinpoint and highlight a highly-effective experimentally-discovered p53 rescue site. ContactWalker’s differential graph method supported by streaming interactive access to MD simulations of almost any size is a novel approach to interactive protein analysis.3 Taking the current p53 efforts together with the previous investigation of AVED, ContactWalker’s visual analytic approach to disease investigation looks promising.
  3 in total

1.  A chemical group graph representation for efficient high-throughput analysis of atomistic protein simulations.

Authors:  Noah C Benson; Valerie Daggett
Journal:  J Bioinform Comput Biol       Date:  2012-06-22       Impact factor: 1.122

2.  Structural consequences of mutations to the α-tocopherol transfer protein associated with the neurodegenerative disease ataxia with vitamin E deficiency.

Authors:  Dennis Bromley; Peter C Anderson; Valerie Daggett
Journal:  Biochemistry       Date:  2013-06-10       Impact factor: 3.162

3.  Halogen-enriched fragment libraries as leads for drug rescue of mutant p53.

Authors:  Rainer Wilcken; Xiangrui Liu; Markus O Zimmermann; Trevor J Rutherford; Alan R Fersht; Andreas C Joerger; Frank M Boeckler
Journal:  J Am Chem Soc       Date:  2012-04-05       Impact factor: 15.419

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.